Skip to content
WELCOME10 — 10% OFF YOUR FIRST ORDER  ·  FREE SHIPPING OVER $300 CAD  ·  COA ON EVERY ORDER

How to Read a Tirzepatide Certificate of Analysis (COA)

A Certificate of Analysis is only useful if you know which number on it matters for the compound in front of you. For Tirzepatide, the informative checks are not the same as for a generic short peptide.

Lipidated dual receptor agonist (GIP / GLP-1), 39-residue chainMetabolic

In plain English

Confirm the weight near 4813.5. As with retatrutide, ask for a clumping measurement alongside purity — standard testing can miss clusters. For a 39-part chain, also look at the separation trace for incomplete versions that sit very close to the main peak.

What Tirzepatide actually is

Tirzepatide is an engineered molecule acting on two receptors in the gut-hormone system involved in blood-sugar regulation. It carries a design detail that is very widely misreported: it was built on a GIP backbone and then modified to also engage GLP-1, whereas most compounds in its class went the other way round.

Supplied for laboratory research use only — not for human or animal use.

Research-grade Tirzepatide

Third-party tested by HPLC and LC-MS, ≥99% purity, with a Certificate of Analysis on every order. Ships across Canada.

Technical detail below

Assays that are informative for Tirzepatide

Method 1RP-HPLC purity (UV 214 nm)
Method 2LC-MS identity / molecular-ion confirmation
Method 3Appearance and reconstitution clarity
Method 4Aggregate content by SEC

What to check on the COA

Confirm the mass near 4813.5 Da. As with retatrutide, aggregate content is the check that RP-HPLC purity alone will not give you. For a 39-residue synthesis, also review the chromatogram for closely eluting deletion sequences.

Characteristic impurity profile

Deletion and truncation sequences, des-acyl species missing the fatty-acid chain.

Verify a Popular Peptides batch

Every batch is third-party tested by HPLC and LC-MS with a published Certificate of Analysis (≥99% purity). Enter a lot number to pull the COA for the exact vial in front of you.

What Tirzepatide is studied for

Dual incretin engagement

Simultaneous GIP and GLP-1 receptor activity from a GIP-derived backbone.

Insulin secretion and glucagon suppression

Core metabolic research endpoints for the incretin class.

Gastric emptying

A well-characterised GLP-1 pathway effect studied in metabolic models.

GIP receptor pharmacology

Whether GIP agonism or antagonism is the productive direction remains an active research debate.

Summarizes published preclinical literature. Provided for research reference only; not a claim of efficacy or a description of human use.

More Tirzepatide reference

Purity & COA reference for other compounds

Tirzepatide overview Tirzepatide calculatorTirzepatide product details

Tirzepatide is supplied strictly as a research chemical for in-vitro laboratory and research use only. It is not intended for human or animal consumption, diagnostic, or therapeutic use. This page is educational laboratory-handling reference information — not medical advice, not usage guidance, and not a protocol.